Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating gabapentin for restoring GABA/glutamate homeostasis in people with co-occurring bipolar disorder and cannabis use disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bipolar Disorder, Cannabis Use | Phase 2 | Status: RECRUITING